Hanmi Control Dispute Reignites as Court Freezes 10 Billion Won in Lim Ju-hyun’s Shares
The "four-party alliance" formed to stabilize management control at Hanmi Pharmaceutical Group has descended into open legal warfare, with major...
Biowatch
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million (approximately 521.
From Retinal Scans to Brain Imaging: South Korea Backs Six Medical AI Tools for Fast-Track Hospital Adoption
Medical AI tools designed to assess cardiovascular risk from retinal images and analyze brain scans for stroke severity...
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy
Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in...
HK inno.N's K-CAB Secures Sixth Indication to Prevent Ulcers from Long-Term NSAID Use
HK inno.N’s gastroesophageal reflux disease drug K-CAB has expanded its approved uses to include the prevention of...
Suwon Nanuri Hospital Offers Free Spine and Joint Consultations for Foreign Workers
Foreign workers living in South Korea and their families often struggle to access healthcare when suffering from spine...
Licensing Windfalls and Exports Split Performance Among Korea’s Top Drugmakers in Q2
South Korea’s five major legacy pharmaceutical companies largely extended their revenue growth in the second quarter,...
Scalp-Injected RNA Hair Loss Drug Completes Phase 1b Dosing in Australia
OliX announced on August 4 that it has completed patient dosing in the Australian Phase 1b clinical trial for OLX104C...
Yuhan Ramps Up OTC Magnesium Push with Dual-Campaign for Liquid and High-Dose 'MagV'
If your lower eyelid twitches or you experience sudden leg cramps, it is common to assume a magnesium deficiency is to...
Jung Yoo-seok Becomes Ilyang Pharmaceutical’s Largest Shareholder, Completing Third-Generation Succession
Ilyang Pharmaceutical’s largest shareholder position has shifted from Chairman Jung Do-eon to his eldest son, CEO and...